Grufity logoGrufity logo

Herbalife Ltd Stock Research

HLF

15.88USD-0.51(-3.11%)Market Closed

Market Summary

USD15.88-0.51
Market Closed
-3.11%

HLF Alerts

HLF Stock Price

HLF RSI Chart

HLF Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

4.84

Price/Sales (Trailing)

0.3

EV/EBITDA

1.54

Price/Free Cashflow

7.93

HLF Price/Sales (Trailing)

HLF Profitability

EBT Margin

8.16%

Return on Assets

11.76%

Free Cashflow Yield

12.61%

HLF Fundamentals

HLF Revenue

Revenue (TTM)

5.2B

Revenue Y/Y

-10.41%

Revenue Q/Q

-8.83%

HLF Earnings

Earnings (TTM)

321.3M

Earnings Y/Y

42.41%

Earnings Q/Q

-33.82%

Price Action

52 Week Range

12.0432.64
(Low)(High)

Last 7 days

-11.6%

Last 30 days

-18.0%

Last 90 days

9.9%

Trailing 12 Months

-49.9%

HLF Financial Health

Current Ratio

1.39

Debt/Cashflow

0.14

HLF Investor Care

Buy Backs (1Y)

2.88%

Diluted EPS (TTM)

3.23

Peers (Alternatives to Herbalife)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
342.4B
80.3B
3.27% -2.35%
23.98
4.26
2.47% -1.59%
86.0B
16.4B
-3.85% -11.87%
56.94
5.26
-7.75% -53.65%
60.4B
18.0B
-2.64% 0.03%
33.83
3.36
3.13% -17.59%
43.1B
20.2B
-1.23% 6.78%
22.27
2.14
3.78% 6.62%
19.1B
7.1B
0.28% 16.83%
43.96
2.71
-0.21% 76.11%
MID-CAP
9.8B
5.3B
3.70% 31.43%
70.53
1.86
4.52% -56.15%
4.3B
1.4B
1.76% 39.81%
36.21
3
12.31% 322.50%
2.1B
2.2B
-7.96% 14.23%
21
0.96
3.72% -10.14%
SMALL-CAP
1.9B
2.2B
-7.44% -16.22%
18.42
0.87
-17.44% -28.85%
1.6B
5.2B
-18.02% -49.95%
4.84
0.3
-10.31% -28.15%
1.1B
1.6B
-6.74% -42.84%
7.45
0.67
4.75% -12.48%
198.6M
437.1M
4.65% -39.49%
15.1
0.45
2.15% -41.44%
104.8M
27.7M
-70.72% -75.29%
-0.92
3.78
-54.38% -604.59%
58.8M
52.7M
-3.01% -20.20%
164.79
1.12
-12.83% -77.69%
43.8M
206.4M
-12.21% -32.62%
-60.64
0.21
-2.54% -107.21%

Financials for Herbalife

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-2.6%5,2045,3425,4775,6375,803
Gross Profit-2.6%4,0314,1374,2534,4054,564
  S&GA Expenses-4.0%1,8101,8861,9241,9602,012
EBITDA3.0%680660700755-
EBITDA Margin5.7%0.13*0.12*0.13*0.13*-
Earnings Before Taxes4.1%425408447499561
EBT Margin6.9%0.08*0.08*0.08*0.09*-
Interest Expenses1.7%139137140145153
Net Income5.3%321305340398447
Net Income Margin8.1%0.06*0.06*0.06*0.07*-
Free Cahsflow-12.4%196224244321-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets0.3%2,7322,7252,8032,8252,820
  Current Assets-2.0%1,3561,3841,4301,4391,432
    Cash Equivalents-4.6%508533581570602
  Inventory8.1%581537554570576
  Net PPE4.0%486468466454442
  Goodwill6.4%93.0088.0092.0096.0095.00
Liabilities-2.2%3,9984,0874,2184,2784,211
  Current Liabilities-0.9%9779861,0541,1001,080
    LT Debt, Current0%30.0030.0029.0029.0029.00
    LT Debt, Non Current-2.3%2,6632,7252,7812,7872,733
  Retained Earnings4.3%-1,204-1,258-1,029-1,087-1,169
  Additional Paid-In Capital4.3%189181186173318
Shares Outstanding0.1%98.0098.0098.0099.00101
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-8.3%353384403481460
  Share Based Compensation-9.9%44.0049.0052.0053.0054.00
Cashflow From Investing2.9%-156-160-163-164-156
Cashflow From Financing18.3%-264-323-467-351-728
  Buy Backs-41.0%1472494254831,011

Risks for HLF

What is the probability of a big loss on HLF?

66.9%


Probability that Herbalife stock will be more than 20% underwater in next one year

61.1%


Probability that Herbalife stock will be more than 30% underwater in next one year.

48.9%


Probability that Herbalife stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does HLF drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Herbalife was unfortunately bought at previous high price.

Drawdowns

Returns for HLF

Cumulative Returns on HLF

-1.5%


10-Year Cumulative Returns

-8.8%


7-Year Cumulative Returns

-20.2%


5-Year Cumulative Returns

-14.3%


3-Year Cumulative Returns

What are the long-term rolling returns for HLF?

FIve years rolling returns for Herbalife.

Annualized Returns

Which funds bought or sold HLF recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
510
1,028,450
1,316,450
-%
2023-02-28
Voya Investment Management LLC
added
6.24
-176,113
682,887
-%
2023-02-27
Parallax Volatility Advisers, L.P.
added
39.32
147,506
3,632,510
0.01%
2023-02-23
Portman Square Capital LLP
new
-
3,454,110
3,454,110
0.26%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
unchanged
-
-5,962
17,038
-%
2023-02-21
MACQUARIE GROUP LTD
added
1,971
452,000
528,000
-%
2023-02-17
Linden Thomas Advisory Services, LLC
new
-
157,028
157,028
0.04%
2023-02-16
MAVERICK CAPITAL LTD
new
-
270,786
270,786
0.01%
2023-02-15
LAZARD ASSET MANAGEMENT LLC
reduced
-33.73
-12,000
11,000
-%
2023-02-15
Chimera Capital Management LLC
new
-
404,394
404,394
0.11%

1–10 of 36

Latest Funds Activity

Are funds buying HLF calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own HLF
No. of Funds

Herbalife News

Nasdaq

Interesting HLF Put Options For May 5th.

Nasdaq,
9 hours ago

Schedule 13G FIlings of Herbalife

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
windacre partnership llc
9.45%
9,253,500
SC 13G
Feb 13, 2023
renaissance technologies llc
6.65%
6,512,364
SC 13G/A
Feb 09, 2023
morgan stanley
5.4%
5,255,046
SC 13G
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
13.06%
12,785,306
SC 13G/A
Feb 07, 2023
blackrock inc.
7.8%
7,663,315
SC 13G
Jun 10, 2022
capital research global investors
0.0%
0
SC 13G/A
Jun 07, 2022
route one investment company, l.p.
10.0%
10,845,794
SC 13G/A
Feb 11, 2022
renaissance technologies llc
7.49%
8,394,564
SC 13G/A
Feb 11, 2022
capital research global investors
7.3%
8,132,290
SC 13G/A

HLF Fair Value

Herbalife fair value in different scenarios

The table shows the Fair Value estimates for Herbalife for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

16.89

6.36%

23.49

47.92%

40.37

154.22%

52.17

228.53%

63.91

302.46%
Current Inflation

15.09

-4.97%

20.90

31.61%

35.56

123.93%

45.64

187.41%

55.69

250.69%
Very High Inflation

12.81

-19.33%

17.66

11.21%

29.70

87.03%

37.83

138.22%

45.94

189.29%

Historical Herbalife Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Herbalife

View All Filings
Date Filed Form Type Document
Mar 14, 2023
ARS
ARS
Mar 14, 2023
DEF 14A
DEF 14A
Mar 14, 2023
DEFA14A
DEFA14A
Mar 07, 2023
4
Insider Trading
Mar 03, 2023
PRE 14A
PRE 14A
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading

Latest Insider Trading transactions for HLF

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-03
Amezquita Alexander
sold (taxes)
-783
20.62
-38.00
chief financial officer
2023-02-25
Hienrich Edi
sold (taxes)
-11,493
19.48
-590
regional pres. emea & india
2023-02-25
Schissel Mark J
sold (taxes)
-10,129
19.48
-520
chief operating officer
2023-02-25
Irani Jehangir D
sold (taxes)
-9,155
19.48
-470
svp, pao
2023-02-25
Lamberti Frank
sold (taxes)
-5,980
19.48
-307
regional pres. americas
2023-02-25
Amezquita Alexander
sold (taxes)
-9,856
19.48
-506
chief financial officer
2023-02-25
Wang Henry C
sold (taxes)
-10,129
19.48
-520
evp, general counsel
2023-02-25
Hienrich Edi
sold (taxes)
-25,012
19.48
-1,284
regional pres. emea & india
2023-02-22
Mulligan Donal L
bought
289,800
19.32
15,000
-
2023-02-21
L'Helias Sophie
bought
165,620
19.4847
8,500
-

1–10 of 50

About Herbalife

HLF Income Statement

2022-12-31
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Net sales$ 5,204.4$ 5,802.8$ 5,541.8
Cost of sales1,173.61,239.31,150.6
Gross profit4,030.84,563.54,391.2
Royalty overrides1,690.11,833.71,690.1
Selling, general, and administrative expenses1,810.42,012.12,075.0
Other operating income(14.9)(16.4)(14.5)
Operating income545.2734.1640.6
Interest expense139.3153.1133.0
Interest income6.14.48.8
Other (income) expense, net(12.8)24.60.0
Income before income taxes424.8560.8516.4
Income taxes103.5113.6143.8
Net income$ 321.3$ 447.2$ 372.6
Earnings per share:   
Basic$ 3.26$ 4.22$ 2.83
Diluted$ 3.23$ 4.13$ 2.77
Weighted-average shares outstanding:   
Basic98.5105.9131.5
Diluted99.5108.3134.5

HLF Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 508.0$ 601.5
Receivables, net of allowance for doubtful accounts70.666.9
Inventories580.7575.7
Prepaid expenses and other current assets196.8187.7
Total current assets1,356.11,431.8
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization486.3442.1
Operating lease right-of-use assets207.1220.0
Marketing-related intangibles and other intangible assets, net315.7317.3
Goodwill93.295.4
Other assets273.6313.2
Total assets2,732.02,819.8
Current liabilities:  
Accounts payable89.892.0
Royalty overrides343.3363.2
Current portion of long-term debt29.529.4
Other current liabilities514.0595.8
Total current liabilities976.61,080.4
Long-term debt, net of current portion2,662.52,733.2
Non-current operating lease liabilities192.4201.2
Other non-current liabilities166.4196.5
Total liabilities3,997.94,211.3
Commitments and contingencies
Shareholders, deficit:  
Common shares, $0.0005 par value; 2.0 billion shares authorized; 97.9 million (2022) and 100.8 million (2021) shares outstanding0.10.1
Paid-in capital in excess of par value188.7318.1
Accumulated other comprehensive loss(250.2)(211.8)
Accumulated deficit(1,204.5)(1,169.0)
Treasury stock, at cost, - million (2022) and 10.0 million (2021) shares0.0(328.9)
Total shareholders' deficit(1,265.9)(1,391.5)
Total liabilities and shareholders' deficit$ 2,732.0$ 2,819.8